Skip to main content

Advertisement

SpringerLink
Log in

Issues in the management of endocarditis caused by resistant gram-positive organisms

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Most cases of infective endocarditis (IE) are caused by gram-positive bacteria such as enterococci, streptococci, and staphylococci. Increasing resistance among these organisms has eroded the utility of mainstay antibiotics and complicated the management of this difficult-to-treat infection. Clinical experience with newer gram-positive antibiotics to treat IE is limited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. File TM, Jr.: Overview of resistance in the 1990s. Chest 1999, 115:3S-8S.

    Article  PubMed  Google Scholar 

  2. Serra P, Brandimarte C, Martino P, et al.: Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies. Arch Intern Med 1977, 137:1562–1567.

    Article  PubMed  CAS  Google Scholar 

  3. Megran DW: Enterococcal endocarditis. Clin Infect Dis 1992, 15:63–71.

    PubMed  CAS  Google Scholar 

  4. Kazanjian PH: Infective endocarditis--review of 60 cases treated in community hospitals. Infect Dis Clin Pract 1993, 2:41–46.

    Article  Google Scholar 

  5. Hricak V Jr, Kovacik J, Marx P, et al.: Endocarditis due to Enterococcus faecalis: risk factors and outcome in twentyone cases from a five year national survey. Scand J Infect Dis 1998, 30:540–541.

    Article  PubMed  Google Scholar 

  6. Wilson WR, Wilkowske CJ, Wright AJ, et al.: Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med 1984, 100:816–823.

    PubMed  CAS  Google Scholar 

  7. Krogstad DJ, Parquette AR: Defective killing of enterococci--a common property of anti-microbial agents acting on the cell wall. Antimicrob Agents Chemother 1980, 17:965–968.

    PubMed  CAS  Google Scholar 

  8. Le T, Bayer AS: Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 2003, 36:615–621. This comprehensive review summarizes the data supporting the use of combination antibiotic therapy in IE.

    Article  PubMed  Google Scholar 

  9. Bayer AS, Bolger AF, Taubert KA, et al.: Diagnosis and management of infective endocarditis and its complications. Circulation 1998, 98:2936–2948. This is an excellent overview of the management of endocarditis.

    PubMed  CAS  Google Scholar 

  10. Wilson WR, Karchmer AW, Dajani AS, et al.: Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association. JAMA 1995, 274:1706–1713. Important study.

    Article  PubMed  CAS  Google Scholar 

  11. Olaison L, Schadewitz K: Enterococcal endocarditis in Sweden, 1995–1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 2001, 34:159–166. Important study.

    Article  PubMed  Google Scholar 

  12. Moellering RC Jr, Watson BK, Kunz LJ: Endocarditis due to group D streptococci. Comparison of disease caused by Streptococcus bovis with that produced by the enterococci. Am J Med 1974, 57:239–250.

    Article  PubMed  Google Scholar 

  13. Mandell GL, Kaye D, Levison ME, et al.: Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med 1970, 125:258–264.

    Article  PubMed  CAS  Google Scholar 

  14. Watanakunakorn C, Bakie C: Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci. Antimicrob Agents Chemother 1973, 4:120–124.

    PubMed  CAS  Google Scholar 

  15. Fernandezguerrero ML, Barros C, Tudela JLR, et al.: Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis. Eur J Clin Microbiol Infect Dis 1988, 7:525–527.

    Article  CAS  Google Scholar 

  16. Brandt CM, Rouse MS, Laue NW, et al.: Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis 1996, 173:909–913.

    PubMed  CAS  Google Scholar 

  17. Gavalda J, Torres C, Tenorio C, et al.: Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother 1999, 43:639–646.

    PubMed  CAS  Google Scholar 

  18. Murray BE: Vancomycin-resistant enterococcal infections. N Engl J Med 2000, 342:710–721. This is an elegant review of the pathogenesis, epidemiology, and resistance of the Enterococcus.

    Article  PubMed  CAS  Google Scholar 

  19. Mekonen ET, Noskin GA, Hacek DM, et al.: Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium. Microb Drug Resist 1995, 1:249–253.

    Article  PubMed  CAS  Google Scholar 

  20. McNeil SA, Clark NM, Chandrasekar PH, et al.: Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin). Clin Infect Dis 2000, 30:403–404.

    Article  PubMed  CAS  Google Scholar 

  21. Babcock HM, Ritchie DJ, Christiansen E, et al.: Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. Clin Infect Dis 2001, 32:1373–1375.

    Article  PubMed  CAS  Google Scholar 

  22. Safdar A, Bryan CS, Stinson S, et al.: Prosthetic valve endocarditis due to vancomycin-resistant Enterococcus faecium: treatment with chloramphenicol plus minocycline. Clin Infect Dis 2002, 34:E61-E63.

    Article  PubMed  Google Scholar 

  23. Cha R, Rybak MJ: Daptomycin against multiple drug-resistant Staphylococcus and Enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Diagn Microbiol Infect Dis 2003, 47:539–546.

    Article  PubMed  CAS  Google Scholar 

  24. Akins RL, Rybak MJ: Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 2001, 45:454–459.

    Article  PubMed  CAS  Google Scholar 

  25. Levy CS, Kogulan P, Gill VJ, et al.: Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy. Clin Infect Dis 2001, 33:577–579.

    Article  PubMed  CAS  Google Scholar 

  26. Ugolini V, Pacifico A, Smitherman TC, et al.: Pneumococcal endocarditis update: analysis of 10 cases diagnosed between 1974 and 1984. Am Heart J 1986, 112:813–819.

    Article  PubMed  CAS  Google Scholar 

  27. Powderly WG, Stanley SL Jr, Medoff G: Pneumococcal endocarditis: report of a series and review of the literature. Rev Infect Dis 1986, 8:786–791.

    PubMed  CAS  Google Scholar 

  28. Bruyn GA, Thompson J, Van der Meer JW: Pneumococcal endocarditis in adult patients. A report of five cases and review of the literature. Q J Med 1990, 74:33–40.

    PubMed  CAS  Google Scholar 

  29. Siegel M, Timpone J: Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review. Clin Infect Dis 2001, 32:972–974.

    Article  PubMed  CAS  Google Scholar 

  30. Martinez E, Miro JM, Almirante B, et al.: Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults. Clin Infect Dis 2002, 35:130–139. Important study.

    Article  PubMed  Google Scholar 

  31. Aronin SI, Mukherjee SK, West JC, et al.: Review of pneumococcal endocarditis in adults in the penicillin era. Clin Infect Dis 1998, 26:165–171.

    PubMed  CAS  Google Scholar 

  32. Karchmer AW, Archer GL, Dismukes WE: Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med 1983, 98:447–455. Important study.

    PubMed  CAS  Google Scholar 

  33. Whitener C, Caputo GM, Weitekamp MR, et al.: Endocarditis due to coagulase-negative staphylococci. Microbiologic, epidemiologic, and clinical considerations. Infect Dis Clin North Am 1993, 7:81–96. Important study.

    PubMed  CAS  Google Scholar 

  34. Etienne J, Eykyn SJ: Increase in native valve endocarditis caused by coagulase negative staphylococci: an Anglo-French clinical and microbiological study. Br Heart J 1990, 64:381–384.

    PubMed  CAS  Google Scholar 

  35. Caputo GM, Archer GL, Calderwood SB, et al.: Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features. Am J Med 1987, 83:619–625. Important study.

    Article  PubMed  CAS  Google Scholar 

  36. Drinkovic D, Morris AJ, Pottumarthy S, et al.: Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis. J Antimicrob Chemother 2003, 52:820–825.

    Article  PubMed  CAS  Google Scholar 

  37. Arber N, Militianu A, Ben Yehuda A, et al.: Native valve Staphylococcus epidermidis endocarditis: report of seven cases and review of the literature. Am J Med 1991, 90:758–762.

    PubMed  CAS  Google Scholar 

  38. Sanabria TJ, Alpert JS, Goldberg R, et al.: Increasing frequency of staphylococcal infective endocarditis. Experience at a university hospital, 1981 through 1988. Arch Intern Med 1990, 150:1305–1309.

    Article  PubMed  CAS  Google Scholar 

  39. Cabell CH, Jollis JG, Peterson GE, et al.: Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002, 162:90–94. Important study.

    Article  PubMed  Google Scholar 

  40. Fowler VG Jr, Sanders LL, Kong LK, et al.: Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999, 28:106–114. Important study.

    PubMed  Google Scholar 

  41. Jensen AG, Wachmann CH, Poulsen KB, et al.: Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med 1999, 159:1437–1444. Important study.

    Article  PubMed  CAS  Google Scholar 

  42. Heiro M, Nikoskelainen J, Engblom E, et al.: Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 2000, 160:2781–2787. Important study.

    Article  PubMed  CAS  Google Scholar 

  43. Roder BL, Wandall DA, Espersen F, et al.: Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med 1997, 102:379–386.

    Article  PubMed  CAS  Google Scholar 

  44. Tunkel AR, Kaye D: Neurologic complications of infective endocarditis. Neurol Clin 1993, 11:419–440.

    PubMed  CAS  Google Scholar 

  45. Sandre RM, Shafran SD: Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis 1996, 22:276–286.

    PubMed  CAS  Google Scholar 

  46. Roder BL, Wandall DA, Frimodt-Moller N, et al.: Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 1999, 159:462–469.

    Article  PubMed  CAS  Google Scholar 

  47. Petti CA, Fowler VG Jr.: Staphylococcus aureus bacteremia and endocarditis. Cardiol Clin 2003, 21:219–233, vii. This is a thorough review of the literature regarding S. aureus bloodstream infections.

    Article  PubMed  Google Scholar 

  48. Sklaver AR, Hoffman TA, Greenman RL: Staphylococcal endocarditis in addicts. South Med J 1978, 71:638–643.

    PubMed  CAS  Google Scholar 

  49. Murray HW, Wigley FM, Mann JJ, et al.: Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy. Arch Intern Med 1976, 136:480–483.

    Article  PubMed  CAS  Google Scholar 

  50. Korzeniowski O, Sande MA: Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med 1982, 97:496–503. Important study.

    PubMed  CAS  Google Scholar 

  51. Steckelberg JM, Rouse MS, Tallan BM, et al.: Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis. Antimicrob Agents Chemother 1993, 37:554–558.

    PubMed  CAS  Google Scholar 

  52. Nannini EC, Singh KV, Murray BE: Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue. Clin Infect Dis 2003, 37:1194–1198.

    Article  PubMed  Google Scholar 

  53. Levine DP, Fromm BS, Reddy BR: Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 1991, 115:674–680. Important study.

    PubMed  CAS  Google Scholar 

  54. Small PM, Chambers HF: Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990, 34:1227–1231.

    PubMed  CAS  Google Scholar 

  55. Fortun J, Navas E, Martinez-Beltran J, et al.: Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis 2001, 33:120–125.

    Article  PubMed  CAS  Google Scholar 

  56. Ruiz ME, Guerrero IC, Tuazon CU: Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid. Clin Infect Dis 2002, 35:1018–1020.

    Article  PubMed  Google Scholar 

  57. Eliopoulos GM: Quinupristin-dalfopristin and linezolid: evidence and opinion. Clin Infect Dis 2003, 36:473–481.

    Article  PubMed  Google Scholar 

  58. Drew RH, Perfect JR, Srinath L, et al.: Treatment of methicillinresistant staphylococcus aureus infections with quinupristindalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group. J Antimicrob Chemother 2000, 46:775–784.

    Article  PubMed  CAS  Google Scholar 

  59. Olsen KM, Rebuck JA, Rupp ME: Arthralgias and myalgias related to quinupristin-dalfopristin administration. Clin Infect Dis 2001, 32:e83-e86.

    Article  PubMed  CAS  Google Scholar 

  60. Sakoulas G, Eliopoulos GM, Alder J, et al.: Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003, 47:1714–1718.

    Article  PubMed  CAS  Google Scholar 

  61. Chambers HF, Miller RT, Newman MD: Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med 1988, 109:619–624.

    PubMed  CAS  Google Scholar 

  62. DiNubile MJ: Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med 1994, 121:873–876.

    PubMed  CAS  Google Scholar 

  63. Ribera E, Gomez-Jimenez J, Cortes E, et al.: Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Intern Med 1996, 125:969–974.

    PubMed  CAS  Google Scholar 

  64. Mylonakis E, Calderwood SB: Infective endocarditis in adults. N Engl J Med 2001, 345:1318–1330. This is an outstanding review of current issues associated with endocarditis.

    Article  PubMed  CAS  Google Scholar 

  65. Dworkin RJ, Lee BL, Sande MA, et al.: Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 1989, 2:1071–1073.

    Article  PubMed  CAS  Google Scholar 

  66. Heldman AW, Hartert TV, Ray SC, et al.: Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 1996, 101:68–76.

    Article  PubMed  CAS  Google Scholar 

  67. Rouse MS, Wilcox RM, Henry NK, et al.: Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother 1990, 34:273–276.

    PubMed  CAS  Google Scholar 

  68. Karchmer AW, Longworth DL: Infections of intracardiac devices. Infect Dis Clin North Am 2002, 16:477–505, xii.

    Article  PubMed  Google Scholar 

  69. Stanbridge TN, Isalska BJ: Aspects of prosthetic valve endocarditis. J Infect 1997, 35:1–6.

    Article  PubMed  CAS  Google Scholar 

  70. John MD, Hibberd PL, Karchmer AW, et al.: Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis 1998, 26:1302–1309. Important study.

    PubMed  CAS  Google Scholar 

  71. Vikram HR, Buenconsejo J, Hasbun R, et al.: Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis--a propensity analysis. JAMA 2003, 290:3207–3214. Important study.

    Article  PubMed  CAS  Google Scholar 

  72. Anguera I, Miro JM, de Lazzari E, et al.: Prognostic factors of mortality in aorto-cavitary fistulous tract formation in infective endocarditis [poster 46 2003]. Abstract presented at the 7th International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections. Chamonix Mont-Blanc, France, June 26, 2003.

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Room 34228 Red Zone Duke South, Box 3281, 27710, Durham, NC, USA

    Vance G. Fowler Jr MD, MHS

Authors
  1. Martin E. Stryjewski MD, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vivian H. Chu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christopher H. Cabell MD, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vance G. Fowler Jr MD, MHS
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stryjewski, M.E., Chu, V.H., Cabell, C.H. et al. Issues in the management of endocarditis caused by resistant gram-positive organisms. Curr Infect Dis Rep 6, 283–291 (2004). https://doi.org/10.1007/s11908-004-0049-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-004-0049-7

Keywords

Search

Navigation